Edinburgh, UK, 16 November 2006: Ardana plc (LSE:ARA), announces today that it has commenced the marketing in the United Kingdom of Emselex®, a once a day treatment for symptoms of overactive bladder (OAB) in collaboration with Novartis Pharmaceuticals UK Limited (“Novartis”).
